On Tuesday, August 27th, the FDA finalized its Guidance for Institutional Review Boards, Clinical Investigators and Sponsors on Institutional Review Board Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an Investigational New Drug/Investigational Device Exemption is Needed. Continue reading
Author Archive: AZBio
UA-Developed Apps Aid Arizona Cotton Farmers
By Gabrielle Fimbres for the College of Agriculture and Life Sciences, August 27, 2013
Two apps – Mobile Cotton and Differentiating Diseases of Early Season Cotton – are helping Arizona cotton growers manage their crops from anywhere.Continue reading
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
- Attractive Addition to Amgen’s Leading Oncology Portfolio and Pipeline
- Kyprolis® (carfilzomib) for Injection is at Early Stages of Launch in Multiple Myeloma; Showing Strong Physician Support
- Acquisition Expected to Contribute to Growth and Value for Amgen Shareholders
- Amgen to Host Analyst/Investor Call Monday at 8:30 a.m. EDT (5:30 a.m. PDT)Continue reading
New tool enhances the search for genetic mutations
Written by: Richard Harth
Science Writer: Biodesign Institute richard.harth@asu.eduContinue reading
Meet Amanda Grimes – Arizona Bioscience Educator of the Year
Amanda Grimes of the Mesa Public Schools Biotechnology Academy to receive the 2013 Michael A. Cusanovich Arizona Bioscience Educator of the Year Award at the 8th Annual AZBio Awards on October 10, 2013.Continue reading
Mayo Clinic to Open Stem Cell Laboratory in Phoenix
Mayo Clinic in Arizona, with one of the most active bone marrow transplant programs in United States, will open its own stem cell laboratory in summer 2014. The laboratory will be initially dedicated to storing and processing stem cells used for bone marrow transplants at Mayo Clinic Hospital and Phoenix Children’s Hospital.Continue reading
Scott Arden Joins Xeridiem® as Product Development Director
Xeridiem has expanded the leadership team with the appointment of Scott Arden as Product Development Director, he has extensive experience in new product development.Continue reading
ASU Spinout HealthTell Raises $4 million in New Funding for Innovative Cancer Tests
AZ-based company developing inexpensive tools for individual health monitoringContinue reading
BioDirection Completes $3.95 Million Series A Financing
Tucson Arizona Company Developing Rapid Point of Care Testing for Mild Traumatic Brain Injury (Concussion)Continue reading
Illumina, Qiagen set to drive adoption of NGS testing for clinical use with new platforms (BioPharm Insight)
- Next-generation sequencing could help find answers behind misunderstood pediatric diseases
- Results are now available within a day or two
- Costs of genomic sequencing have dropped dramatically